JP Morgan Chase
IDXX icon

JP Morgan Chase’s Idexx Laboratories IDXX Stock Holding History

JP Morgan Chase’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-25,000
Closed -$1.96M – 4865
2016
Q1 		$1.96M Buy
+25,000
New +$1.8M ﹤0.01% 2714

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase's IDXX Position: Q1 2026 in Review

JP Morgan Chase increased its Idexx Laboratories (IDXX) stake by 16% in Q1 2026, buying an estimated $68.4M and bringing the position to 779,882 shares worth $434M. The position accounts for 0.03% of the portfolio, ranked #444.

JP Morgan Chase first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $556M in Q3 2025. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • JP Morgan Chase held 779,882 shares of Idexx Laboratories worth $434M as of Q1 2026.
  • JP Morgan Chase bought 106,654 Idexx Laboratories shares in Q1 2026, an estimated $68.4M.
  • Idexx Laboratories made up 0.03% of JP Morgan Chase's portfolio in Q1 2026, its #444 holding.
  • JP Morgan Chase first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Idexx Laboratories position peaked at $556M in Q3 2025.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.